home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Vaccine Development and Approval: Phase 2 and Beyond

 
  July 28, 2011  
     
 
Loews Philadelphia Hotel, Philadelphia, PA USA
Nov 7 2011 7:00AM - Nov 8 2011 3:00PM


Address Issues and Challenges of Vaccine Development from Phase 2 to Licensure.

The unique demands of vaccine trials require discussion among all stakeholders with clarification of expectations and sharing of lessons learned. This conference will provide and opportunity to present key issues and case studies from industry and regulatory professionals on such topics as adaptive designs for vaccine trials, regulatory expectations, new pathways to approval and data challenges.

FEATURED TOPICS
•  Adaptive Designs for Phase 2/3 Vaccine Trials - Strengths and Weaknesses
•  New Approaches to Approval: Licensure based on Immune Correlates
•  Regulatory Challenges: Study Designs and Acceptance of Non-domestic Data


Event Code:
11023
 
 
Organized by: DIA
Invited Speakers: See website for speaker information
 
Deadline for Abstracts: Call contact
 
Registration:

Marjorie Davis

DIA

215.442.6176 

marjorie.davis@diahome.org 

E-mail: marjorie.davis@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.